V-Flex Plus PTX Drug Eluting Coronary Stent

Inclusion Criteria: * Patient must be eligible to undergo planned treatment of a single de novo lesion in a native coronary artery. * Patient must be an acceptable candidate for coronary artery bypass surgery * Patient or legal guardian must have given informed consent * Patient agrees to return at one month for an office visit to assess cardiovascular status and at 6 months for an office visit to assess cardiovascular status, an IVUS examination and a diagnostic angiogram. Exclusion Criteria: * Patient must be less than 18 years old * Patient has history of bleeding diathesis or coagulopathy or will refuse blood transfusions. * Patient is simultaneously participating in another investigative interventional cardiovascular device or drug study. * Patient has known hypersensitivity or contraindication to aspirin, clopidogrel, or stainless steel, or a sensitivity to contrast dye. * Women of child bearing potential. * Patient has other medical condition that any cause non-compliance with the protocol, confound the results or is associated with limited life expectancy.